The Association for Accessible Medicines (AAM), is seeking a Senior Director, Sciences and Regulatory Affairs to join its team. This is an invaluable opportunity to work at a dynamic, growing trade association at the center of some of the most important public policy issues facing our nation. The working environment is high-energy, fast-paced and the culture is entrepreneurial.
This position, in partnership with the SVP, Sciences & Regulatory Affairs and other members of the Sciences & Regulatory Affairs Team, is responsible for the development and oversight of the Association for Accessible Medicines’ (AAM) Sciences & Regulatory Affairs (SRA) initiatives. Initiatives are achieved by working with members of the Sciences and Regulatory Advisory Working Group (SRAWG), other Sciences & Regulatory Affairs personnel from member-companies, AAM SRA staff, and staff across all AAM functional groups. The role is also responsible for member communications and training opportunities for SRA initiatives.
The Association for Accessible Medicines improves access to safe, quality, effective medicine. For more information about the Association for Accessible Medicines and to see the full job description please visit www.accessiblemeds.org/careers.
Candidates need to have a Bachelor’s degree in a science-related field and 8+ years of experience in a pharmaceutical science related role, with 5+ years in government regulatory agency (FDA) and/or a pharmaceutical industry regulatory department. Advanced knowledge of the regulatory process and regulatory issues of the generic pharmaceutical industry is required and experience with ANDA dossier development and filing is preferred.
Additional Salary Information: Base + Bonus + Benefits
About Association for Accessible Medicines
AAM works to ensure more generic and biosimilar medicines are more accessible to more people who need them.
The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality and effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.